02616 CSTONE PHARMA-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.60X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 72.2% | Net Margin | N/A |
| Total Debt/Equity | 97.8% | Return on Equity | N/A |
| Price/Book | 22.97X | Return on Assets | N/A |
| (HKD 6.920) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | -97.00 | -404.77 | -1,012.08 | -2,348.47 | -1,449.08 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +76.0 | +60.0 | +56.9 | -62.1 | +37.3 |
| Earnings Per Share (HKD) | -0.076 | -0.321 | -0.863 | -2.016 | -1.385 |
| Earnings Per Share Growth (%) | +76.3 | +62.9 | +57.2 | -45.5 | +48.1 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 0.301 | 0.392 | 0.420 | 1.244 | 2.987 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 407.205 | 463.842 | -12.2 | 481.363 |
| Operating Result | -91.585 | -546.125 | -83.2 | -902.678 |
| Profit Before Taxation | -91.207 | -367.234 | -75.2 | -902.678 |
| Profit /( Loss) After Taxation | -91.207 | -367.234 | -75.2 | -902.678 |
| Net Profit | -91.207 | -367.234 | -75.2 | -902.678 |
| Earnings Per Share () | -0.0760 | -0.3205 | -76.3 | -0.8629 |
| Announcement Date | 2025-03-27 | 2024-03-27 | NA | 2023-03-15 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
